Pavone-Macaluso, M <br/><br/>
EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group.  [electronic resource] 

 -  Progress in clinical and biological research  1989 
 - 111-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0361-7742 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Antagonists--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Clinical Trials as Topic<br/>Cyproterone--analogs & derivatives<br/>Cyproterone Acetate<br/>Diethylstilbestrol--therapeutic use<br/>Europe<br/>Humans<br/>Male<br/>Medroxyprogesterone--analogs & derivatives<br/>Medroxyprogesterone Acetate<br/>Multicenter Studies as Topic<br/>Prostatic Neoplasms--drug therapy<br/>Random Allocation